Hachiya Hitoshi, Hirao Kenzo, Takahashi Atsushi, Nagata Yasutoshi, Suzuki Kenji, Maeda Shingo, Sasaki Takeshi, Kawabata Mihoko, Isobe Mitsuaki, Iesaka Yoshito
Department of Cardiovascular Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan.
J Cardiovasc Electrophysiol. 2007 Apr;18(4):392-8. doi: 10.1111/j.1540-8167.2006.00753.x. Epub 2007 Feb 7.
Dormant pulmonary vein (PV) conduction can be provoked by adenosine triphosphate (ATP) after extensive encircling pulmonary vein isolation (EEPVI). However, the clinical implication of reconnection between the left atrium (LA) and isolated PVs provoked by ATP (ATP-reconnection) remains unknown.
We studied the clinical consequences of ATP-reconnection during intravenous isoproterenol infusion (ISP-infusion). EEPVI severs conduction between the LA and ipsilateral PVs at their junction. Radiofrequency energy is applied at a distance from the PV ostia guided by double Lasso catheters placed within the ipsilateral superior and inferior PVs. This study comprised 82 patients (67 men, 56 +/- 9 years old) with atrial fibrillation (AF) who underwent injection of ATP during ISP infusion after successful EEPVI (ATP(+) group). We compared clinical characteristics of 170 patients who underwent earlier EEPVI prior to our use of ATP injection after successful EEPVI (ATP(N/D) group) with those of ATP(+) group patients who underwent one session of EEPVI. ATP-reconnection occurred in 34 (41%) of 82 ATP(+) group patients. Additional radiofrequency applications were performed to eliminate ATP-reconnection in all ipsilateral PVs. Continuous ATP-reconnection of more than 20 seconds duration occurred in six (7.3%) of 82 patients. A total of 102 (60%) of 170 patients in the ATP(N/D) group had no recurrence of AF, whereas 60 (73%) of 82 ATP(+) group patients who underwent only one EEPVI session have had no recurrence of AF in a 6.1 +/- 3.3-month follow-up period (P = 0.04).
Radiofrequency application for provoked ATP-reconnection may reduce clinical AF recurrence.
在广泛的肺静脉隔离术(EEPVI)后,三磷酸腺苷(ATP)可诱发肺静脉(PV)隐匿性传导。然而,由ATP诱发的左心房(LA)与隔离的肺静脉之间重新连接(ATP重新连接)的临床意义仍不明确。
我们研究了静脉输注异丙肾上腺素(ISP输注)期间ATP重新连接的临床后果。EEPVI切断了LA与同侧PV在其交界处的传导。在置于同侧上、下肺静脉内的双套索导管引导下,在距肺静脉口一定距离处施加射频能量。本研究纳入了82例心房颤动(AF)患者(67例男性,年龄56±9岁),这些患者在成功进行EEPVI后于ISP输注期间注射了ATP(ATP阳性组)。我们将170例在我们使用ATP注射之前更早进行EEPVI的患者(ATP阴性/未进行组)的临床特征与接受了一次EEPVI的ATP阳性组患者的临床特征进行了比较。82例ATP阳性组患者中有34例(41%)发生了ATP重新连接。对所有同侧肺静脉进行了额外的射频应用以消除ATP重新连接。82例患者中有6例(7.3%)出现持续超过20秒的ATP重新连接。ATP阴性/未进行组的170例患者中有102例(60%)未复发AF,而在6.1±3.3个月的随访期内,仅接受一次EEPVI的82例ATP阳性组患者中有60例(73%)未复发AF(P = 0.04)。
针对诱发的ATP重新连接进行射频应用可能会降低临床AF复发率。